Загрузка...
Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal
Background: L-triiodothyronine (LT3) is a substitute for levothyroxine (LT4) for thyroid cancer (TC) patients during the preparation for nuclear medicine procedures, and it is used in combination with LT4 in patients who do not respond to the standard treatment for hypothyroidism. This therapy is co...
Сохранить в:
| Опубликовано в: : | Thyroid |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Mary Ann Liebert, Inc., publishers
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6797066/ https://ncbi.nlm.nih.gov/pubmed/31364488 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2019.0101 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|